Korro Bio, Inc. revenue for the last year amounted to 2.27 M USD, the most of which — 2.27 M USD — came from its highest performing source at the moment, RNA-editing Technology, the year earlier bringing 14.07 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Korro Bio, Inc. 2.27 M USD, and the year before that — 14.07 M USD.